[Immunohistochemical and molecular-pathologic investigations in dermatohistology]

M J Flaig1, U Puchta, C A Sander

  • 1Klinik und Poliklinik für Dermatologie und Allergologie der Ludwig-Maximilians-Universität München, Frauenlobstrasse 9-11, 80337 München. Michael.Flaig@med.uni-muenchen.de

Insights

Morphologic diagnosis in pathology is limited. Immunohistochemical methods are essential for identifying proteins like surface markers, aiding in the diagnosis of tumors.

Area of Science:

  • Pathologic anatomy
  • Molecular biology
  • Immunohistochemistry

Context:

  • Morphologic diagnosis has limitations in general and dermatologic pathology.
  • Advances in basic sciences necessitate new diagnostic approaches.
  • Evaluating lymphocytic and mesenchymal tumors requires more than morphology.

Purpose:

  • To highlight the limitations of pure morphologic diagnosis.
  • To emphasize the importance of molecular biological methods in pathology.
  • To showcase immunohistochemistry as a key diagnostic tool.

Summary:

  • Modern pathology relies on identifying protein expression (e.g., CD3, cyclin D, actin) in tumor cells.
  • Molecular biological techniques allow for the identification of cellular and extracellular macromolecules.
  • Immunohistochemistry is crucial for the selective identification of proteins on tissue sections.

Impact:

  • Enhances diagnostic accuracy in complex cases.
  • Integrates molecular insights into routine pathology.
  • Improves the diagnosis and understanding of tumors.